Sat, Aug 30, 2014, 11:13 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • swhitemd50 swhitemd50 Nov 3, 2011 7:50 AM Flag

    What is the rev potential for the CF drug?

    Of course, until Vertex has drugs that effectively treat most CF patients, this 3 billion figure will not be realized. However, if just half the 2200 patients that can benefit from Kayleideco pay $200,000/year, then the revenue is 1100 X $200,000 = 220 million per year or $1 per share.

93.57+0.77(+0.83%)Aug 29 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Burger King Worldwide, Inc.
NYSEFri, Aug 29, 2014 4:02 PM EDT
Synaptics Inc.
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT